Abeona Therapeutics Inc.
ABEO
$5.60
$0.071.18%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 60.89% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 60.89% | -- | |||
| Cost of Revenue | 28.30% | 103.00% | |||
| Gross Profit | 14.48% | 12.22% | |||
| SG&A Expenses | 3.83% | -2.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.08% | 17.96% | |||
| Operating Income | -0.53% | 4.61% | |||
| Income Before Tax | 17.42% | -1.56% | |||
| Income Tax Expenses | 100.93% | 98.59% | |||
| Earnings from Continuing Operations | 16.54% | -296.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 16.54% | -296.43% | |||
| EBIT | -0.53% | 4.61% | |||
| EBITDA | -1.34% | 5.82% | |||
| EPS Basic | 18.60% | -289.59% | |||
| Normalized Basic EPS | 19.44% | 0.26% | |||
| EPS Diluted | 18.60% | -270.50% | |||
| Normalized Diluted EPS | 19.44% | 0.26% | |||
| Average Basic Shares Outstanding | 2.54% | 1.80% | |||
| Average Diluted Shares Outstanding | 2.54% | 1.80% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||